Correlation Between Viridian Therapeutics and Medpace Holdings
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Medpace Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Medpace Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Medpace Holdings, you can compare the effects of market volatilities on Viridian Therapeutics and Medpace Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Medpace Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Medpace Holdings.
Diversification Opportunities for Viridian Therapeutics and Medpace Holdings
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and Medpace is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Medpace Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medpace Holdings and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Medpace Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medpace Holdings has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Medpace Holdings go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Medpace Holdings
Given the investment horizon of 90 days Viridian Therapeutics is expected to under-perform the Medpace Holdings. In addition to that, Viridian Therapeutics is 1.09 times more volatile than Medpace Holdings. It trades about -0.1 of its total potential returns per unit of risk. Medpace Holdings is currently generating about 0.05 per unit of volatility. If you would invest 32,935 in Medpace Holdings on August 28, 2024 and sell it today you would earn a total of 847.00 from holding Medpace Holdings or generate 2.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Medpace Holdings
Performance |
| Timeline |
| Viridian Therapeutics |
| Medpace Holdings |
Viridian Therapeutics and Medpace Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Medpace Holdings
The main advantage of trading using opposite Viridian Therapeutics and Medpace Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Medpace Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will offset losses from the drop in Medpace Holdings' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Medpace Holdings vs. IQVIA Holdings | Medpace Holdings vs. Neogen | Medpace Holdings vs. ICON PLC | Medpace Holdings vs. Qiagen NV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |